Login |Links | Newsletter | Contact
 News archive
 Newsletter Archive
 EU News
 Sign up for ScanBaltNews
 Summer School in Lapino
 ESF calls for more and better medical imaging rese
 Scandinavian universities join forces to commercialise nanotech
 The Danish Ministry of Science, Technology and Development supports innovation in ScanBalt BioRegion
 Nordplus programmes open to the Baltic States
 New ScanBalt member: the Group for Bioethics in Life Sciences of the Jagiellonian University
 ScanBalt Forum 2008- the first announcement
 Grants for participation at "The first brain aquaporin meeting" in Oslo
 Postgraduate course of the ScanBalt Agrobiotechnology network concluded
 Prof. Glosnicka heads a succesful startup company in the growing biotech industry
 Potocnik calls on Member States to work together on cancer research
 FP7 call: Marie Curie programme
 Commission adopts new health strategy
 FP7 call for proposals: Capacities programme
 FP7 call for proposals: International Cooperation programme
 ScanBalt BioRegion to Collaborate on Cancer
 37 scientists coming back to Lithuania
 Rise of the Nordic warriors
 Biological physics creates diagnostics of the future
 EU Commission signs with ScanBalt to support Small and Medium sized Companies
 Danish model to encourage brain gain
EUROPEAN CENTRE FOR MODERN DRUG DISCOVERY ESTABLISHED IN HAMBURG

HAMBURG, Germany, September 03, 2007 /PRNewswire-FirstCall/ -- Hamburg is on its way to becoming a leading hub of Europe's academic drug discovery, with the northern German city's town hall today announcing the foundation of European ScreeningPort GmbH, a company that will run a state-of-the-art drug discovery service centre. European ScreeningPort is being established with the support of the German Federal Ministry of Education and Research, the Free and Hanseatic City of Hamburg, Evotec AG and Norgenta, the north German life science agency. Although still in an early phase, the project has already raised more than EUR 7 million in financing.

Read more here.


design: triip